> Patients

Learn about acute decompensated heart failure & find useful information about NATRECOR® (nesiritide).
> Healthcare Professionals

NATRECOR® (nesiritide) is a recombinant form of human B-type natriuretic peptide (BNP).
Acute Heart Failure accounts for approximately one million hospital admissions each year in the United States.
From 1987 to 2001, there were no new FDA-approved drugs to treat acute heart failure. Then in 2001, NATRECOR® (nesiritide) was approved, marking an important evolution in the understanding and treatment of heart disease. Today, NATRECOR® is prescribed across the U.S. for the treatment of acutely decompensated congestive heart failure patients with dyspnea (shortness of breath) at rest or with minimal activity (such as talking, eating or bathing).


What is NATRECOR® (nesiritide)?
How does it work?